HomeAI · summaries
Storia in 4 fonti
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Patients can pay $499 in cash per month for three dose sizes of Ozempic through the company's direct-to-consumer pharmacy and GoodRx, among other platforms.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Patients can pay $499 in cash per month for three dose sizes of Ozempic through the company's direct-to-consumer pharmacy and GoodRx, among other platforms.
- ·
telegraph.co.uk
Drugmaker halves price of Ozempic for Americans amid Trump crackdown
Novo Nordisk insists its decision is unrelated to pressure from the US president
- ·
ft.com
Novo Nordisk halves US price of Ozempic
Danish group’s shares rise after it cuts cost for blockbuster diabetes and weight-loss drug for patients without insurance
- ·
independent.co.uk
Diabetes drug Ozempic will cost half-price for US patients paying cash
The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes patients